Neurocrine Biosciences, Inc. (BIT:1NBIX)
133.55
-6.05 (-4.33%)
At close: Dec 5, 2025
| Market Cap | 13.33B |
| Revenue (ttm) | 2.29B |
| Net Income (ttm) | 364.78M |
| Shares Out | n/a |
| EPS (ttm) | 3.57 |
| PE Ratio | 36.54 |
| Forward PE | 16.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 2 |
| Open | n/a |
| Previous Close | 139.60 |
| Day's Range | n/a |
| 52-Week Range | 92.16 - 139.60 |
| Beta | n/a |
| RSI | 55.80 |
| Earnings Date | Feb 9, 2026 |